• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home The Classics Obstetrics and Gynecology Classics

High fertilization rates following intracytoplasmic sperm injection (ICSI) [Classics Series]

byLeah Hawkins Bressler, MD, MPH
November 14, 2015
in Obstetrics and Gynecology Classics, The Classics
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. Among infertile couples with poor prognosis and/or severe male factor infertility, intracytoplasmic sperm injection (ICSI) was associated with higher fertilization, implantation, and pregnancy rates.

Original Date of Publication: April 1993

Study Rundown: Male factor infertility is a vexing problem in the field of reproductive endocrinology and infertility. Couples with severe male factor infertility often fail standard in vitro fertilization (IVF) treatment or are considered ineligible. Part of the difficulty diagnosing and treating male factor infertility relates to a history of underdiagnosis. In fact, semen analysis was not a routine part of the standard infertility evaluation until the 1980’s. One decade later, treatment options for male factor remained limited but were quickly expanding. These included subzonal insemination (SUZI; injection of spermatozoa below the zona pellucida, into the perivitelline space) and partial zona pellucida dissection. However, these treatments were associated with fertilization rates of just 20-25%. Researchers proposed that injection of spermatozoa directly into oocyte cytoplasm, a technique that would soon be referred to as ICSI, might improve pregnancy rates. Two small studies reported use of this procedure and their results suggested improvement in clinical outcomes with ICSI but did not directly compare outcomes with SUZI.

In this landmark study, authors investigated ICSI outcomes in a large cohort and directly compared ICSI to SUZI outcomes in 11 sister oocytes. Results demonstrated markedly improved outcomes associated with ICSI (39% clinical pregnancy rate) and, compared with SUZI, ICSI conferred a greater than 18-fold increase in fertilization rate. This landmark study was the first to directly compare ICSI to SUZI and the first to demonstrate improved pregnancy rates in a large cohort. Strengths included head-to-head comparison, single-center study using one clinic and lab to minimize variability in procedures and techniques. Limitations included lack of live birth or adverse effects assessment (e.g. incidence of monozygotic twinning, congenital anomalies, etc). Future investigations would go on to characterize ICSI as the best treatment option for couples with severe male factor infertility. Adverse effects assessments would demonstrate that ICSI is associated with a mildly increased risk of genitourinary abnormalities (e.g. male factor infertility, hypospadias) but not with an increase in major congenital anomalies compared to baseline in the infertile population.

Click to read the study in Obstetrics & Gynecology

In-Depth [prospective cohort study]: A total of 150 infertile couples who failed standard IVF procedures (<5% fertilization rate) or were deemed ineligible for IVF due to severe male factor infertility (< 500 000 progressively motile spermatozoa or failed SUZI procedure) underwent ICSI. Additionally, controlled comparison was performed between the SUZI and ICSI procedure in 11 sibling oocytes. Primary outcome was the clinical pregnancy rate per embryo transfer. Secondary outcomes included fertilization rate, in vitro maturation and frequency of oocytes damaged by the ICSI procedure.

Among a cohort of 150 infertile couples, ICSI was associated with a 64% fertilization rate, of which 71% developed into embryos and were transferred or cryopreserved. The clinical pregnancy rate per embryo transfer was 39%, represented by 53 clinical pregnancies. Compared to a 4% fertilization rate with SUZI, ICSI was associated with a 73% fertilization rate on sibling oocytes (p < 0.01). Only 8% of oocytes were damaged in the process of ICSI.

RELATED REPORTS

Double embryo transfer may be associated with neonatal risks

No difference in live birth rates between intracytoplasmic sperm injection and conventional in-vitro fertilization for couples with non-male factor infertility

#VisualAbstract: Effect of Folic Acid and Zinc Supplementation in Men on Semen Quality and Live Birth Among Couples Undergoing Infertility Treatment

Image: PD

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: infertilityreproductive endocrinology
Previous Post

Risk of developing autoimmune diseases increased after childhood cancer

Next Post

Solitary kidney not associated with contrast-induced nephropathy

RelatedReports

Assisted conception not associated with increased pediatric cancer risk
Endocrinology

Double embryo transfer may be associated with neonatal risks

December 19, 2022
Mental retardation associated with IVF treatment
Chronic Disease

No difference in live birth rates between intracytoplasmic sperm injection and conventional in-vitro fertilization for couples with non-male factor infertility

May 6, 2021
#VisualAbstract: Effect of Folic Acid and Zinc Supplementation in Men on Semen Quality and Live Birth Among Couples Undergoing Infertility Treatment
StudyGraphics

#VisualAbstract: Effect of Folic Acid and Zinc Supplementation in Men on Semen Quality and Live Birth Among Couples Undergoing Infertility Treatment

March 8, 2020
Large proportion of late preterm infants and older admitted to the NICU
Obstetrics

Folic acid and zinc supplementation in men not associated with increased fertility

February 12, 2020
Next Post
Solitary kidney not associated with contrast-induced nephropathy

Solitary kidney not associated with contrast-induced nephropathy

Increased severe maternal morbidity with multiple gestation pregnancies

Increased severe maternal morbidity with multiple gestation pregnancies

Antibiotic use in animals contributes to bacterial resistance in consumers

Antibiotic use in animals contributes to bacterial resistance in consumers

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Transcarotid artery revascularization not associated with a significant difference in 30-day risk of stroke, death and myocardial infarction compared to carotid endarterectomy
  • Drinking characteristics in adolescence predict alcohol behaviors in early adulthood
  • Sodium-glucose co-transporter-2 inhibitors may decrease risk of in-stent thrombosis
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options